In this study, using BDL-induced hepatic fibrosis, we found that MP-40 significantly improved survival rates, downregulated ALT, AST, and HYP, and mitigated damage in the livers of rats and mice. The gene discussed is GPT; the disease is Hepatic fibrosis.